Clinical Trial Update: A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 two-way crossover study assessed the effect of food on the pharmacokinetics of Pazopanib in cancer patients to inform dosing considerations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Phase 1 | Status: COMPLETED